vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Celcuity Inc. (CELC). Click either name above to swap in a different company.
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Celcuity Inc. is a clinical-stage biotechnology company specializing in oncology. It develops personalized cancer treatment solutions through its proprietary functional cell analysis technology, targeting unmet medical needs for patients with hard-to-treat solid tumors, with primary operations in the U.S. and partnerships across global biopharmaceutical networks.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | — | ||
| Q3 24 | $38.4M | — |
| Q3 25 | $5.7M | — | ||
| Q3 24 | $-14.9M | — |
| Q3 25 | 69.9% | — | ||
| Q3 24 | 52.6% | — |
| Q3 25 | 11.5% | — | ||
| Q3 24 | -32.9% | — |
| Q3 25 | 6.8% | — | ||
| Q3 24 | -38.8% | — |
| Q3 25 | $0.10 | — | ||
| Q3 24 | $-1.47 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
